Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Fuji

Showing results (61-70 of 191) with videos related to

Pageof 20
Sort By:
Haematologica|June 23, 2022
Pseudo-progression of adult T-cell leukemia-lymphoma after cord blood transplantationShigeo Fuji, Jun-Ichirou Yasunaga, Eri Watanabe, et al.
Bone Marrow Transplantation|August 23, 2019
Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?Takafumi Shichijo, Shigeo Fuji, Arnon Nagler, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
A sinus of Valsalva-right atrium fistula without aneurysm formationYumiko Kanzaki, Fumio Terasaki, Shigeo Fuji, et al.
Microbes and Infection|October 3, 2017
Pneumococcal polysaccharide vaccination in allogeneic hematopoietic stem cell transplantation recipients: a prospective single-center studyKeiji Okinaka, Yukihiro Akeda, Saiko Kurosawa, et al.
Bone Marrow Transplantation|May 26, 2018
Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphomaShigeo Fuji, Saiko Kurosawa, Yoshihiro Inamoto, et al.
Expert Review of Hematology|April 9, 2025
Comprehensive review of morphological diagnosis of adult T-cell leukemia-lymphomaShigeo Fuji, Masakazu Muta, Tomoko Hisakata, et al.
Experimental Cell Research|September 6, 2002
Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 geneNaohisa Yoshioka, Shigeo Fuji, Misuzu Shimakage, et al.
Japanese Journal of Clinical Oncology|July 25, 2025
Cross-organ examination of hematologic toxicities from immune checkpoint inhibitors: insights from real-world dataSayako Yuda, Yuma Tada, Yasuhiro Shingai, et al.
Blood Cell Therapy|June 8, 2026
Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant RecipientsShigeo Fuji, Makiko Suga, Yuma Tada, et al.
Clinical Transplantation|October 22, 2024
Persistently Low IgG2 Levels in a Subset of Patients Following Hematopoietic Cell TransplantationShigeo Fuji, Makiko Suga, Yuma Tada, et al.
Pageof 20

Showing results (61-70 of 191) with videos related to

Sort By:
Pageof 20
Haematologica|June 23, 2022
Pseudo-progression of adult T-cell leukemia-lymphoma after cord blood transplantationShigeo Fuji, Jun-Ichirou Yasunaga, Eri Watanabe, et al.
Bone Marrow Transplantation|August 23, 2019
Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?Takafumi Shichijo, Shigeo Fuji, Arnon Nagler, et al.
Internal Medicine (Tokyo, Japan)|April 29, 2010
A sinus of Valsalva-right atrium fistula without aneurysm formationYumiko Kanzaki, Fumio Terasaki, Shigeo Fuji, et al.
Microbes and Infection|October 3, 2017
Pneumococcal polysaccharide vaccination in allogeneic hematopoietic stem cell transplantation recipients: a prospective single-center studyKeiji Okinaka, Yukihiro Akeda, Saiko Kurosawa, et al.
Bone Marrow Transplantation|May 26, 2018
Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphomaShigeo Fuji, Saiko Kurosawa, Yoshihiro Inamoto, et al.
Expert Review of Hematology|April 9, 2025
Comprehensive review of morphological diagnosis of adult T-cell leukemia-lymphomaShigeo Fuji, Masakazu Muta, Tomoko Hisakata, et al.
Experimental Cell Research|September 6, 2002
Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 geneNaohisa Yoshioka, Shigeo Fuji, Misuzu Shimakage, et al.
Japanese Journal of Clinical Oncology|July 25, 2025
Cross-organ examination of hematologic toxicities from immune checkpoint inhibitors: insights from real-world dataSayako Yuda, Yuma Tada, Yasuhiro Shingai, et al.
Blood Cell Therapy|June 8, 2026
Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant RecipientsShigeo Fuji, Makiko Suga, Yuma Tada, et al.
Clinical Transplantation|October 22, 2024
Persistently Low IgG2 Levels in a Subset of Patients Following Hematopoietic Cell TransplantationShigeo Fuji, Makiko Suga, Yuma Tada, et al.
Pageof 20